MERIDIAN BIOSCIENCE INC Quarterly Net Cash Provided by (Used in) Operating Activities in USD from Q4 2010 to Q4 2022
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Meridian Bioscience Inc quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q4 2010 to Q4 2022.
- Meridian Bioscience Inc Net Cash Provided by (Used in) Operating Activities for the quarter ending December 31, 2022 was -$2.35M, a 107% decline year-over-year.
- Meridian Bioscience Inc annual Net Cash Provided by (Used in) Operating Activities for 2022 was $82.4M, a 23.2% increase from 2021.
- Meridian Bioscience Inc annual Net Cash Provided by (Used in) Operating Activities for 2021 was $66.9M, a 39.4% increase from 2020.
- Meridian Bioscience Inc annual Net Cash Provided by (Used in) Operating Activities for 2020 was $48M, a 32.6% increase from 2019.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)